AI + live data · analyst records & stock signals

Leaderboard Membership Builder

Connect your AI client via MCP

Endpoint (paste into an MCP client — anonymous, free, no key)

https://mcp.koalcheck.com/mcp

Or copy this and send it to your AI to set it up:

Add the "koalcheck" MCP server to my client and connect. It is a remote Streamable-HTTP server at https://mcp.koalcheck.com/mcp — connect anonymously, no API key or login needed (the free tools work right away). If my client supports a remote/HTTP MCP server directly, just use that URL. If my client config only accepts a local command (e.g. Claude Desktop's mcpServers, which rejects a bare "url"), bridge it with command "npx" and args ["-y","mcp-remote","https://mcp.koalcheck.com/mcp"]. Then tell me to fully restart the client, and list the koalcheck tools you can call. It provides US-equity research tools built on an analyst track-record engine (who has actually been right, priced vs SPY, cross-checked with SEC & FINRA).

Capabilities User guide

$IQV

BULLISH2026-07-29

Price around the call

↑ 2026-07-29

By horizon✓ hit+6.3%

1d

✗ -1.9%

5d

✗ -5.9%

21d

✓ +6.3%

Original post

美股翻倍哥 · 2026-07-29

【美股标普成分股 $IQV 看涨390】全球最大医疗数据+AI+CRO双寡头； IQVIA 是全球生命科学数据与 CRO 领域的“绝对双寡头”之一。在全球临床试验外包（CRO）及生命科学商业分析市场中，其综合份额估计约占 18% ~ 22%，高居全球第一。客户涵盖全球前 100 大制药公司、中小型生物技术公司（Biotech）、医疗器械企业及政府监管机构。其核心优势在于客户黏性极高，全球顶尖 20 大药企几乎全部深度绑定其数据与软件系统。在手未完成订单创历史新高：其 R&D Solutions 部门的储备订单金额增至 342 亿美元（同比增长 7.5%），其中约 92 亿美元将在未来 12 个月内转化为收入，为公司未来业绩提供了极高的能见度。 2026年，AI 智能化代理在顶尖药企全面落地：公司将 Generative AI 和 AI Agents 深度嵌入其数据平台与临床流程中，目前全球前 20 大药企中有 19 家已部署 IQVIA 的 AI 解决方案，带动商业化与研发部门的有机增长明显加速。上述分析仅代表个人观点，非投资建议。 #IQV #IQVIA #美股 #AI医疗 #CRO $IQV